Sight Sciences (SGHT) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Sight Sciences (SGHT) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -54.61% |
| 10 | Sight Sciences | 274.03 Mn | 189.07 Mn | 16.98 Mn | 10.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.79% |
| Dec 31, 2025 | 65.83% |
| Sep 30, 2025 | -177.78% |
| Jun 30, 2025 | -106.13% |
| Mar 31, 2025 | -299.71% |
| Dec 31, 2024 | -24.94% |
| Sep 30, 2024 | 64.12% |
| Jun 30, 2024 | -11.37% |
| Mar 31, 2024 | -70.19% |
| Dec 31, 2023 | 99.57% |
| Sep 30, 2023 | -77.80% |
| Jun 30, 2023 | -8.26% |
| Mar 31, 2023 | -83.68% |
| Dec 31, 2022 | -26,101.91% |
| Sep 30, 2022 | -1,609.32% |
| Jun 30, 2022 | -420.29% |
| Mar 31, 2022 | 91.83% |
| Dec 31, 2021 | -10.28% |
| Sep 30, 2021 | 98.85% |
| Jun 30, 2021 | 98.02% |